Behind the Study: PRAME Associated with Increased Metastatic Risk
Dr. Matthew G. Field discusses his 2016 study published by Oncotarget, entitled: “Epigenetic reprogramming and... read more
June 7, 2021
Category: Oncotarget
Trending With Impact: Novel Biomarkers in Bladder Cancer
Researchers from the University of Houston and UT Southwestern Medical Center conducted a study which... read more
June 3, 2021
Can CEA Be Used as a Biomarker for SCCA?
Squamous cell carcinoma of the anal canal (SCCA) most commonly affects women and is closely... read more
May 26, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #11
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
May 25, 2021
Trending With Impact: RNA Modification Regulatory Proteins in Melanoma
Researchers analyzed various publicly available datasets and identified two RNA modification regulatory proteins that are... read more
May 20, 2021
Behind the Study: Potential Therapeutic Target in Breast Cancer Cells
Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study... read more
May 17, 2021
Tomivosertib Versus Acute Myeloid Leukemia
In the cover paper chosen for Oncotarget’s Volume 12, Issue 10, researchers investigated the... read more
May 12, 2021
Table of Contents: Oncotarget’s Volume 12, Issue #10
Read short summaries of the latest oncology-focused research published in this week’s issue of... read more
May 11, 2021
Behind the Study: Extending Survival in Glioma Models
Dr. Gregory Riggins from Johns Hopkins University discusses his 2017 study published by Oncotarget, entitled, "... read more
May 10, 2021
Trending with Impact: Composite Score May Further Classify HCC
In this trending study, the association between IGF/CTP composite scores, overall survival, and progression-free... read more
May 7, 2021